Ceraflex Occluder

Next-Generation Occluder Systems with 360° Flexible Delivery and Ceramic-Coated Technology

Lifetech Scientific developed the CeraFlex Series as an advanced family of transcatheter closure devices designed for ASD, PDA, and PFO interventions. The CeraFlex Series combines enhanced ceramic-coated implant technology with highly flexible delivery architecture, making it one of the most innovative structural heart occluder platforms in modern interventional cardiology.

One of the most distinctive innovations of the CeraFlex Series is its proprietary 360-degree flexible delivery system. Unlike conventional rigid connection mechanisms, this advanced flexible design allows the occluder device to move more naturally during deployment and adapt more effectively to patient anatomy. This flexibility provides important advantages, particularly in complex septal anatomies.

The 360° Flex delivery technology improves alignment between the occluder and the septal structure by enabling a more mobile connection between the device and delivery cable. This design helps facilitate parallel positioning against the septum and supports more stable and controlled implantation during ASD and PFO closure procedures.

Another major feature of the CeraFlex platform is its ceramic-coated nitinol structure. Lifetech Scientific utilizes a titanium nitride-based ceramic coating technology developed to enhance implant biocompatibility and improve implant surface performance. This advanced coating strategy provides important advantages for long-term structural heart implant applications.

One of the key benefits of ceramic coating technology is its contribution to reducing nickel ion release from the implant surface. In addition, the smoother implant surface may support improved endothelialization after implantation. These characteristics represent important innovations for long-term implant stability and biological compatibility.

The CeraFlex ASD Occluder is specifically designed for percutaneous closure of secundum atrial septal defects. Its soft-disc architecture and advanced flexible connection system help improve anatomical adaptation and procedural control during implantation.

The CeraFlex PFO Occluder is optimized for patent foramen ovale closure procedures. Its low-profile structure, soft-disc technology, and flexible delivery mechanism support stable implantation while improving septal conformity and procedural safety.

Within the series, the CeraFlex PDA Occluder systems are engineered to accommodate multiple ductal anatomies. Their conical design structure and controlled expansion mechanism help achieve secure ductal closure while maintaining procedural precision. The low-profile delivery system offers additional benefits, especially in pediatric interventions.

The CeraFlex delivery platform also supports controlled retrieval and repositioning functionality. Operators can reposition or retrieve the device when necessary, providing additional procedural confidence and improved safety during complex structural heart interventions.

Through minimally invasive transcatheter treatment strategies, the CeraFlex Series offers important advantages over conventional surgical repair approaches, including reduced procedural trauma, shorter hospital stays, and faster patient recovery. As a result, transcatheter structural heart therapies continue to expand rapidly in modern cardiology practice.

In clinical applications, the CeraFlex Series is recognized for its enhanced biocompatibility strategy, ceramic-coated implant technology, and highly flexible 360° delivery architecture. The system is particularly valued for improving operator control and implantation stability during structural heart interventions.

In summary, the CeraFlex Series represents an advanced family of transcatheter closure systems developed for ASD, PDA, and PFO procedures. Through its 360° flexible delivery system, ceramic-coated nitinol technology, and controlled implantation capabilities, the CeraFlex Series provides an innovative solution for modern interventional cardiology.